IPIRA Startups

IPIRA Startups

Lucira Health

Brief Description Lucira Health is revolutionizing the way infectious diseases are prevented, diagnosed, and monitored by developing the tools necessary to empower people to become knowledgeable about their health. We produce inexpensive, disposable health diagnostic hardware that transforms any smartphone into a portable, real-time health-monitoring device for rapid, accessible, multiplexed analysis of bodily fluids anywhere in the world.

Formerly known as Diassess, Inc.

Lucira Health had an initial public offering on the Nasdaq stock exchange under the ticker symbol of LHDX...

Hybrid Wisdom Labs, Inc.

Brief Description

Hybrid Wisdom Labs patented and launched the “Collaborative Discovery Engine”, a scalable way for companies to rapidly generate realtime insight from their customers and employees.

Acquired by SurveyMonkey in 2012.

Timeline 2011. Company founded. 2012. Acquired by SurveyMonkey. Inventors

Ephrat Bitton, Siamak Faridani, Kenneth Yigael Goldberg, David Wong

Quick Flash Technologies

Brief Description Electrochromic Solutions.

Manufacturer of manually controlled transition lenses intended to protect eyesight. The company's product offers color-changing sunglasses that have lenses which will allow users to adjust the shade of sunglasses with e-tint technology and with a light sensor to control the electricity applied to the lenses, enabling long-term drivers and outdoor workers to quickly adjust the depth of the mirror in any condition for any light.

The company also has a product line of dynamic, energy-saving smart windows designed to change transparency based...

Inapill

Brief Description

Inapill is developing novel therapeutics that tune immune cell metabolism (immunometabolism) to treat diseases caused by immune system overactivation and excessive inflammation.

Timeline 2023. Company founded; tenant at Bakar Labs, in the UC Berkeley Bakar BioEnginuity Hub Inventors

Kaoru Saijo, Greg Timblin

Lyterian Therapeutics, Inc.

Brief Description

Lyterian Therapeutics is committed to developing transformative medicines for patients by co-opting physiologically relevant protein homeostatic mechanisms to regulate genetically-validated targets. Lyterian is derived from λυτήριος or lutḗrios, which means termination, healing, or end of disease. Disease resolution is coordinated by endogenous and exogenous agents that recruit cells and other effectors to the site of injury. Lyterian Therapeutics medicines are inspired by the logic that orchestrates homeostatic equilibria and drives healing.

Timeline 2022....

Elenae Therapeutics

Brief Description

Applying antisense oligonucleotide technology to target coronaviruses, including SARS-CoV-2, the virus that causes COVID-19.

Timeline 2021. Company founded Inventors

Anders Naar, Sakari Kauppinen

DNA Nanobots, LLC

Brief Description

With a portfolio of existing IP, DNA Nanobots develops products for targeted therapeutics and functionalized gene delivery. We have a dual approach, building partnerships to provide development expertise in the functionalization of DNA nanotechnology with experience in Gene Delivery, Vaccine Development, Targeted Drug Delivery, Biosensing, Immunotherapy, and Drug Discovery.

Timeline 2021. Company founded. Inventors

Jennifer Doudna, Enrique Lin Shiao, Rachael Lew

Intellia

Brief Description

Intellia is a leading genome editing company focused on the development of proprietary, potentially curative therapeutics utilizing a recently developed biological tool known as the CRISPR/Cas9 system. Intellia leverages leading scientific expertise, clinical development experience, and intellectual property position to unlock broad therapeutic applications of CRISPR/Cas9 genome editing and develop a potential new drug class.

Timeline 2014. Company founded. Inventors

Jennifer Doudna, Emmanuelle Charpentier, James Doudna Cate, Krzysztof...

Varada Agriculture

Brief Description

Varada Agriculture is transforming pest management to reduce crop loss with proprietary RNA interference (RNAi) technology. The company's biodegradable products are safer for workers and consumers, while also minimizing residue impact on the environment. The company's RNAi technology uses inhibitory RNA molecules uniquely designed to work on a target organism without impacting beneficial organisms in nature. This method follows the Integrated Pest Management Plan principles, which recommend highly targeted pest control.

Founder and CEO Jyoti Taneja was a postdoc...

Intropic Materials

Brief Description

Intropic Materials is developing truly compostable plastic and other self-degrading products that can be composted or perfectly recycled. The company combines the performance of proteins with a patented stabilization technology to build better materials that address the world's plastic waste problem.

Enzymes are nature’s chemists. They handle the reactions that let life happen, can be engineered for our purposes, and can even break down plastics! However they tend to struggle outside of their comfort zone, the cell. This limits our ability to use them in...